Emmaus Life Sciences Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
EMMA Over the counter 2834 https://www.emmausmedical.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Emmaus Life Sciences Inc

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA - May 31st, 2023 6:11 pm
Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update - May 15th, 2023 1:30 pm
Emmaus Life Sciences Provides Interim Shipment Data - Apr 3rd, 2023 3:00 pm
Emmaus Life Sciences Reports 2022 Financial Results and Provides Business Update - Mar 31st, 2023 8:15 pm
Dr. Niihara Meets with Local Indian Governor - Dec 20th, 2022 3:00 pm
Dr. Niihara Feted by Indian Government in Recognition of the Development of Endari® - Dec 19th, 2022 3:00 pm
Endari® Receives Kuwaiti Marketing Authorization - Dec 7th, 2022 7:25 pm
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Qatar Ministry of Public Health - Nov 17th, 2022 2:30 pm
EMMA: Growing Revenue and Treating Sickle Cell - Nov 15th, 2022 1:15 pm
/C O R R E C T I O N -- Emmaus Life Sciences, Inc./ - Nov 15th, 2022 12:42 am
Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari® - Sep 28th, 2022 10:30 am
Emmaus Life Sciences Reports Q2 2022 Financial Results and Provides Business Update - Aug 15th, 2022 8:30 pm
EMMA: A Stock with Upside Potential - Aug 2nd, 2022 11:12 am
Emmaus Life Sciences Announces Engagement of Strategic Business Relations and Professional Services Advisor - Jul 12th, 2022 2:00 pm
Life Sciences Investor Forum Presentations Now Available for On-Demand Viewing - Jun 24th, 2022 12:35 pm
UPDATE - Life Sciences Investor Forum: Company Executives Present Live June 23rd - Jun 21st, 2022 8:21 pm